B · Normal
On October 15th, the U.S. drug manufacturer sector bucked the market trend and strengthened. AstraZeneca, Bristol-Myers Squibb, and Eli Lilly rose by more than 4%, GlaxoSmithKline, Novo Nordisk, and Novartis rose by more than 3%, and Johnson & Johnson, Pfizer, Merck, and AbbVie rose by more than 2%.
U.S. stock trends 🕐 2026-10-15 22:06

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet